Mass General Brigham, Inc / MAZE
Mass General Brigham, Inc’s Maze Therapeutics Inc Position
Does Mass General Brigham, Inc own Maze Therapeutics Inc (MAZE)? Yes — 240.0K shares worth $7M (+1.53% of its 13F portfolio) as of Q1 2026.
Position Value
$7M
Q1 2026
Shares
240.0K
% of Portfolio
+1.53%
Quarters Held
2
currently held
Position History MAZE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mass General Brigham, Inc’s full portfolio or all institutional holders of MAZE.